1
|
Lavoie JM, Kollmannsberger CK. Current Management of Disseminated Germ Cell Tumors. Urol Clin North Am 2019; 46:377-388. [DOI: 10.1016/j.ucl.2019.04.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
2
|
Lavoie JM, Alcaide M, Fisher RA, Seckl MJ, Morin R, Tinker AV. Targeted Error-Suppressed Detection of Circulating Paternal DNA to Establish a Diagnosis of Gestational Trophoblastic Neoplasm. JCO Precis Oncol 2017; 1:1-6. [DOI: 10.1200/po.17.00154] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Jean-Michel Lavoie
- Jean-Michel Lavoie and Anna V. Tinker, British Columbia Cancer Agency, Vancouver; Miguel Alcaide and Ryan Morin, Simon Fraser University, Burnaby, British Columbia, Canada; and Rosemary A. Fisher and Michael J. Seckl, Imperial College Faculty of Medicine–Charing Cross Campus, London, United Kingdom
| | - Miguel Alcaide
- Jean-Michel Lavoie and Anna V. Tinker, British Columbia Cancer Agency, Vancouver; Miguel Alcaide and Ryan Morin, Simon Fraser University, Burnaby, British Columbia, Canada; and Rosemary A. Fisher and Michael J. Seckl, Imperial College Faculty of Medicine–Charing Cross Campus, London, United Kingdom
| | - Rosemary A. Fisher
- Jean-Michel Lavoie and Anna V. Tinker, British Columbia Cancer Agency, Vancouver; Miguel Alcaide and Ryan Morin, Simon Fraser University, Burnaby, British Columbia, Canada; and Rosemary A. Fisher and Michael J. Seckl, Imperial College Faculty of Medicine–Charing Cross Campus, London, United Kingdom
| | - Michael J. Seckl
- Jean-Michel Lavoie and Anna V. Tinker, British Columbia Cancer Agency, Vancouver; Miguel Alcaide and Ryan Morin, Simon Fraser University, Burnaby, British Columbia, Canada; and Rosemary A. Fisher and Michael J. Seckl, Imperial College Faculty of Medicine–Charing Cross Campus, London, United Kingdom
| | - Ryan Morin
- Jean-Michel Lavoie and Anna V. Tinker, British Columbia Cancer Agency, Vancouver; Miguel Alcaide and Ryan Morin, Simon Fraser University, Burnaby, British Columbia, Canada; and Rosemary A. Fisher and Michael J. Seckl, Imperial College Faculty of Medicine–Charing Cross Campus, London, United Kingdom
| | - Anna V. Tinker
- Jean-Michel Lavoie and Anna V. Tinker, British Columbia Cancer Agency, Vancouver; Miguel Alcaide and Ryan Morin, Simon Fraser University, Burnaby, British Columbia, Canada; and Rosemary A. Fisher and Michael J. Seckl, Imperial College Faculty of Medicine–Charing Cross Campus, London, United Kingdom
| |
Collapse
|
3
|
Graham DM, Plant WD, Mayer NJ, Power DG. Metastatic germ cell tumour following renal transplantation. ACTA ACUST UNITED AC 2013; 36:760-2. [PMID: 24356568 DOI: 10.1159/000356837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Treatment of germ cell tumours with cisplatin-based chemotherapy results in cure for the majority of patients. There is, however, a small but significant mortality rate, reported to be higher in patients with multiple co-morbidities. CASE REPORT We report our management of a renal transplant patient with spina bifida, who was diagnosed with stage IIIC, poor-risk, non-seminomatous germ cell carcinoma. A marker-negative partial response, which has been maintained more than 2 years following completion of treatment, was seen following chemotherapy with cisplatin and etoposide. Performance status has been preserved at pre-treatment levels. CONCLUSION Administration of cisplatin-based chemotherapy is feasible for treatment of renal transplant patients with advanced non-seminomatous germ cell tumours. Treatment strategies require careful planning and monitoring. Dose modifications may be required. This case highlights a favourable outcome in spite of multiple obstacles to ideal management.
Collapse
Affiliation(s)
- Donna M Graham
- Department of Medical Oncology, Cork University Hospital, Ireland
| | | | | | | |
Collapse
|
4
|
Current World Literature. Curr Opin Oncol 2011; 23:303-10. [DOI: 10.1097/cco.0b013e328346cbfa] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|